Clinical control in COPD and therapeutic implications: The EPOCONSUL audit
Therapeutic inertia exists in more than half of uncontrolled patients and is more likely when there is disagreement with the assessment of the physician responsible for the visit, who reported there being good disease control, a situation that was more likely in patients with less history of exacerbations.
Authors
- Juan Luis Rodríguez Hermosa (ORCID: https://orcid.org/0000-0003-0552-2484)
- José Luís López-Campos (ORCID: https://orcid.org/0000-0003-1703-1367)
- Bernardino Alcázar Navarrete (ORCID: https://orcid.org/0000-0003-2356-9366)
- Juan José Soler‐Cataluña (ORCID: https://orcid.org/0000-0003-1134-0783)
- Myriam Calle Rubio (ORCID: https://orcid.org/0000-0002-3890-2742)
- Marc Miravitlles (ORCID: https://orcid.org/0000-0002-9850-9520)
- Manuel Fuentes (ORCID: https://orcid.org/0000-0002-5177-1441)
Institutions
- Universidad Complutense de Madrid (ES)
- Universitat de València (ES)
- Universidad de Granada (ES)
- Instituto de Salud Carlos III (ES)
- Hospital Clínico San Carlos (ES)
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Hospital Universitario Virgen de las Nieves (ES)
- Hospital Arnau de Vilanova (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1371/journal.pone.0314299
- Citations
- 4
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 6.07
Funders
- AstraZeneca
- GlaxoSmithKline
- CSL Behring
- Sociedad Española de Neumología y Cirugía Torácica
- Grifols